@article{1efac796813e4e4cbbf30cdbb28b201c,
title = "The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use",
abstract = "BACKGROUND: The lack of an agreed international minimum approach to measuring cannabis use hinders the integration of multidisciplinary evidence on the psychosocial, neurocognitive, clinical and public health consequences of cannabis use.METHODS: A group of 25 international expert cannabis researchers convened to discuss a multidisciplinary framework for minimum standards to measure cannabis use globally in diverse settings.RESULTS: The expert-based consensus agreed upon a three-layered hierarchical framework. Each layer-universal measures, detailed self-report and biological measures-reflected different research priorities and minimum standards, costs and ease of implementation. Additional work is needed to develop valid and precise assessments.CONCLUSIONS: Consistent use of the proposed framework across research, public health, clinical practice and medical settings would facilitate harmonisation of international evidence on cannabis consumption, related harms and approaches to their mitigation.",
keywords = "assessment, cannabis, dose, iCanntoolkit, measurement, standardisation",
author = "Valentina Lorenzetti and Chandni Hindocha and Kat Petrilli and Paul Griffiths and Jamie Brown and {\'A}lvaro Castillo-Carniglia and Caulkins, {Jonathan P.} and Amir Englund and ElSohly, {Mahmoud A.} and Gage, {Suzanne H.} and Teodora Groshkova and Antoni Gual and David Hammond and Will Lawn and Hugo L{\'o}pez-Pelayo and Jakob Manthey and Claire Mokrysz and Pacula, {Rosalie Liccardo} and {van Laar}, Margriet and Ryan Vandrey and Elle Wadsworth and Adam Winstock and Wayne Hall and Curran, {H. Valerie} and Freeman, {Tom P.}",
note = "Funding Information: The authors received funding from the Society for the Study of Addiction, European Monitoring Centre for Drugs and Drug Addiction. H.L.P. works under the CERCA Programme/Generalitat de Catalunya and receives funding from the Spanish Ministry of Science, Innovation and Universities, Instituto de Salud Carlos III through a {\textquoteleft}Juan Rodes{\textquoteright} contract (JR19/00025). Funding Information: A.G. received funding from Novartis for work outside this area (a phase III cocaine trial). A.E. has received speaker honorarium from GW Pharmaceuticals. A.W. is the founder of the Global Drug Survey. C.H. became a full‐time employee of GW Pharmaceuticals after the consensus meeting. D.H. has served as a paid expert witness on behalf of public health authorities in Canada in response to legal challenges from the cannabis industry. H.L.P. has received honoraria and travel grants from Janssen and Lundbeck. J.B. has received unrestricted research funding to study smoking cessation from companies who manufacture smoking cessation medications (Pfizer and J&J). R.V. receives consulting fees for Canopy Health Innovations and Syqe Medical, and is on the Scientific Advisory Board for MyMD Pharmaceuticals and Artiam Bio. H.V.C. has consulted for Janssen. V.L., H.V.C, W.H., T.P.F., E.W., T.G., W.L., A.C.C., J.P.C., R.L.P., M.v.L., K.P., P.G., M.A.E., S.H.G., J.M. and C.M. have no competing interests to declare. Publisher Copyright: {\textcopyright} 2021 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.",
year = "2021",
month = oct,
day = "27",
doi = "10.1111/add.15702",
language = "English",
journal = "Addiction",
issn = "0965-2140",
publisher = "Wiley-Blackwell Publishing Ltd",
}
